JMOL, New Trial Denied In Depakote Birth Defect Case

(March 10, 2016, 2:43 PM EST) -- CINCINNATI — An Ohio federal judge on March 9 denied a plaintiff’s renewed motion for judgment as a matter of law (JMOL) and a motion for a new trial following a defense verdict in her Depakote birth defect case (Pamela Rheinfrank, et al. v. Abbott Laboratories, et al., No. 13-144, S.D. Ohio, Western Div.).

(Rheinfrank order available. Document #28-160317-007R.)

Pamela Rheinfrank alleges that during her pregnancy, she took Depakote, an anti-epileptic drug, and that her daughter was born with birth defects as a result. During trial...
To view the full article, register now.